These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 1311685

  • 1. Pharmacokinetics of rufloxacin in healthy volunteers.
    Segre G, Cerretani D, Moltoni L, Urso R.
    Eur J Clin Pharmacol; 1992; 42(1):101-5. PubMed ID: 1311685
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of rufloxacin in healthy volunteers after repeated oral doses.
    Mattina R, Bonfiglio G, Cocuzza CE, Gulisano G, Cesana M, Imbimbo BP.
    Chemotherapy; 1991; 37(6):389-97. PubMed ID: 1662127
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and tissue penetration of rufloxacin, a long acting quinolone antimicrobial agent.
    Wise R, Johnson J, O'Sullivan N, Andrews JM, Imbimbo BP.
    J Antimicrob Chemother; 1991 Dec; 28(6):905-9. PubMed ID: 1667783
    [Abstract] [Full Text] [Related]

  • 5. Biliary excretion of rufloxacin in humans.
    Privitera G, Nicastro G, Imbimbo BP, Cesana M, Visconti M, Lombardi F, Tagliabue G, Faleschini E, Colturani F, Franzini P.
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2545-9. PubMed ID: 8109915
    [Abstract] [Full Text] [Related]

  • 6. Multiple-dose pharmacokinetics of rufloxacin in patients with cirrhosis.
    Triger DR, Granai F, Woodcock J, Wise R, Imbimbo BP.
    Hepatology; 1993 Oct; 18(4):847-52. PubMed ID: 8406358
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inter- and intrasubject variabilities in the pharmacokinetics of rufloxacin after single oral administration to healthy volunteers.
    Imbimbo BP, Broccali G, Cesana M, Crema F, Attardo-Parrinello G.
    Antimicrob Agents Chemother; 1991 Feb; 35(2):390-3. PubMed ID: 2024974
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics and safety of NM441, a new quinolone, in healthy male volunteers.
    Nakashima M, Uematsu T, Kosuge K, Okuyama Y, Morino A, Ozaki M, Takebe Y.
    J Clin Pharmacol; 1994 Sep; 34(9):930-7. PubMed ID: 7983237
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of sparfloxacin in humans after single oral administration at doses of 200, 400, 600, and 800 mg.
    Montay G, Bruno R, Vergniol JC, Ebmeier M, Le Roux Y, Guimart C, Frydman A, Chassard D, Thebault JJ.
    J Clin Pharmacol; 1994 Nov; 34(11):1071-6. PubMed ID: 7876398
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.